首页 | 本学科首页   官方微博 | 高级检索  
     


Reducing blood glucose level in TIDM mice by orally administering the silk glands of transgenic hIGF-I silkworms
Authors:Cong Liang  Cao Guangli  Renyu Xue  Zhonghua Pan  Xiaojian Zheng  Zhou Wenlin  Gong Chengliang
Affiliation:Molecular Glycobiology, Research Team for Mechanism of Aging, Tokyo Metropolitan Institute of Gerontology, Foundation for Research on Aging and Promotion of Human Welfare, 35-2 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan
Abstract:Protein O-mannosyltransferase 1 (POMT1) and its homolog, POMT2, are responsible for the catalysis of the first step in O-mannosyl glycan synthesis. Mutations in their genes are associated with a type of congenital muscular dystrophy called Walker-Warburg syndrome. Arg64, Glu78 and Arg138 in the N-terminus region of ScPmt1p, a POMT homolog in Saccharomyces cerevisiae, are important for transferase activity. Arg138 is also essential for complex formation with ScPmt2p. Here we examined the effects of replacing the corresponding residues in human POMT1 and POMT2 with Ala on complex formation and enzymatic activity. The human POMT1 mutants lost almost all transferase activity while the POMT2 mutants retained enzymatic activity. Neither mutant lost its ability to form complexes with the native counter component. These results indicate that ScPmtps and human POMTs have different mechanisms of complex formation. They also suggest that human POMT1 and POMT2 have discrete functions since the effect of amino acid substitutions on enzymatic activity are different.
Keywords:Walker-Warburg syndrome   Muscular dystrophy   Glycosyltransferase   Protein O-mannosyltransferase
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号